ITOS Past Earnings image   This ITOS past earnings page last updated 8/12/2022
ITOS Past Earnings
PeriodPast Earnings DateGAAP
Q2 20228/10/20220.150
Q1 20225/12/20221.820
Q4 20213/23/20224.880
Q3 202111/10/20211.860
Q2 20218/12/2021-0.750
Q1 20215/13/2021-0.390
Q4 20203/24/2021-0.430
Q3 202011/12/2020-0.480
Q2 20209/1/2020-29.490
ITOS Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/10/20220.04B
Q1 20225/12/20220.15B
Q4 20213/23/20220.24B
Q3 202111/10/20210.10B
Q2 20218/12/2021NA
Q1 20215/13/2021NA
Q4 20203/24/2021NA
Q3 202011/12/2020NA
Q2 20209/1/2020NA
Quotes delayed 20 minutes

Email EnvelopeFree ITOS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
ITeos Therapeutics (ITOS) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

IVC Past Earnings
JAGX Past Earnings
JANX Past Earnings
JAZZ Past Earnings
JNCE Past Earnings
JNJ Past Earnings
KALA Past Earnings
KALV Past Earnings
KBR Past Earnings
KDMN Past Earnings

ITOS Past Earnings Q&A

What was the best and worst ITOS past earnings results?
For ITeos Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ITOS past earnings result in our data set was 4.880/share posted in Q4 2021, while the lowest was in Q2 2020 when ITOS posted -29.490/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when ITOS reported 0.24B in revenue, while the quarter with the lowest revenue in our data set was Q2 2021 at NA of revenue.

  Suggested answer: There are 9 ITOS past earnings results in our data set.

On this page we presented the ITOS past earnings date information for ITeos Therapeutics. Reviewing that ITOS Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when ITOS posted gaap of 4.880/share. Meanwhile the lowest ITOS past earnings result was in Q2 2020, when ITOS posted gaap of -29.490/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when ITOS reported 0.24B in revenue, while the smallest revenue quarter was Q2 2021 when ITOS reported NA in revenue.

Any self directed investor doing their due diligence on ITOS or any other given stock can benefit from researching all of the ITeos Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate ITeos Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ITOS. Thanks for visiting, and the next time you need to research ITOS past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: PICO Split History, Top Ten Hedge Funds Holding PCI, RRMS Price Target.

 

ITOS Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.